Retained role of surgery for olfactory neuroblastoma

Head and Neck

Volumn 33, Issue 10, 2011, Pages 1486-1492

  Smee, Robert I ^a   Broadley, Kathryn ^a   Williams, Janet R ^a   Meagher, Nicola S ^b   Bridger, G Patrick ^a  

^a The Prince of Wales Cancer Centre   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

chemotherapy; craniofacial resection; olfactory neuroblastoma; paranasal sinus; radiotherapy

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; AGED; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ESTHESIONEUROBLASTOMA; ETHICS; FEMALE; HEARING IMPAIRMENT; HUMAN; MALE; MEDICAL AUDIT; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PATIENT INFORMATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT PLANNING; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CLINICAL AUDIT; CLINICAL PROTOCOLS; ESTHESIONEUROBLASTOMA, OLFACTORY; ETOPOSIDE; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL CAVITY; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NOSE NEOPLASMS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; YOUNG ADULT;

EID: 80053030879     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21644     Document Type: Review

References (45)

1. Dulguerov P, Allal AS, Calcaterra TC,. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001; 2: 683-690.
2. Harnsberger HR, Wiggins RH III, Hudgins PA, et al. Esthesioneuroblastoma. In: Diagnostic imaging: head and neck. Salt Lake City, UT: Amirsys; 2004. pp 86-89.
3. Lund VJ, Howard D, Wei W, Spittle M,. Olfactory neuroblastoma: past, present, and future? Laryngoscope 2003; 113: 502-507.
4. Skarsgard DP, Groome PA, MacKillop WJ, et al. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer 2000; 88: 1728-1738.
5. Theilgaard SA, Buchwald C, Ingeholm P, Kornum Larsen S, Eriksen JG, Sand Hansen H,. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Otolaryngol 2003; 123: 433-439.
6. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM,. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993; 32: 706-715.
7. Oskouian RJ Jr, Jane JA Sr, Dumont AS, Sheehan JM, Laurent JJ, Levine PA,. Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience. Neurosurg Focus 2002; 12: e4 (abstract).
8. Spaulding CA, Kranyak MS, Constable WC, Stewart FM,. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys 1988; 15: 581-590.
9. Rankin S,. Paranasal sinus neoplasms. In:, Husband JE RR, editor. Imaging in oncology. London: Taylor & Francis; 2004. p 588.
10. Kadish S, Goodman M, Wang CC,. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 37: 1571-1576.
11. Koka VN, Julieron M, Bourhis J, et al. Aesthesioneuroblastoma. J Laryngol Otol 1998; 112: 628-633.
12. Kleihues P, Burger PC, Scheithauer BW,. Tumors of neuroepithelial tissue. In: World Health Organisation international histological classification of tumors: histological typing of tumors of the central nervous system. Berlin: Springer-Verlag; 1993. pp 25-26.
13. Hyams V,. Olfactory neuroblastoma. In:, Hyams VJ, Baksakis JG, Michaels L, editors. Tumors of the upper respiratory tract and ear. Washington DC: Armed Forces Institute of Pathology; 1988. pp 240-248.
14. Biller HF, Lawson W, Sachdev VP, Som P,. Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope 1990; 100: 1199-1201.
15. Eden BV, Debo RF, Larner JM, et al. Esthesioneuroblastoma. Long-term outcome and patterns of failure-the University of Virginia experience. Cancer 1994; 73: 2556-2562.
16. Eich HT, Muller R-P, Micke O, Kocher M, Berthold F, Hero B,. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment? Strahlenther Onkol 2005; 181: 378-384.
17. Irish J, Dasgupta R, Freeman J, et al. Outcome and analysis of the surgical management of esthesioneuroblastoma. J Otolaryngol 1997; 26: 1-7.
18. McLean JN, Nunley SR, Klass C, Moore C, Muller S, Johnstone PAS,. Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg 2007; 136: 998-1002.
19. Rice DH, Stanley RB Jr,. Surgical therapy of tumors of the nasal cavity, ethmoid sinus, and maxillary sinus. In:, Thawley SE, Panje WR, Batsakis JG, et al, editors. Comprehensive management of head and neck tumors, 2nd edition. Philadelphia, PA: WB Saunders; 1999. pp 558-581.
20. Loy AH, Reibel JF, Read PW, et al. Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg 2006; 132: 134-138.
21. Eriksen JG, Bastholt L, Krogdahl AS, Hansen O, Joergensen KE,. Esthesioneuroblastoma-what is the optimal treatment? Acta Oncol 2000; 39: 231-235.
22. Polin RS, Sheehan JP, Chenelle AG, et al. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience. Neurosurgery 1998; 42: 1029-1037.
23. Perez CA, Thorstad, WL,. Unusual nonepithelial tumors of the head and neck. In:, Halperin E, Perez C, Brady L, editors. Perez and Brady's principles and practice of radiation oncology. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2008. pp 1012-1019.
24. Chao KS, Kaplan C, Simpson JR, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck 2001; 23: 749-757.
25. Porter A, Bernold D, Giannini C, et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neuro-Oncol 2008; 90: 201-204.
26. Roux FX, Brasnu D, Villavicencio R, Menard M, Bassot V, Devaux B,. Esthesioneuroblastomas. Could a preoperative chemotherapy improve their prognosis? Neuro-Chirurgie 1991; 37: 248-252.
27. Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27: 835-842.
28. Unger F, Walch C, Stammberger H, Papaefthymiou G, Haselsberger K, Pendl G,. Olfactory neuroblastoma (esthesioneuroblastoma): report of six cases treated by a novel combination of endoscopic surgery and radiosurgery. Minim Invasive Neurosurg 2001; 44: 79-84.
29. Walch C, Stammberger H, Anderhuber W, Unger F, Kole W, Feichtinger K,. The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment. Laryngoscope 2000; 110: 635-640.
30. Castelnuovo P, Bignami M, Delu G, Battaglia P, Bignardi M, Dallan I,. Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience. Head Neck 2007; 29: 845-850.
31. Devaiah AK, Larsen C, Tawfik O, O'Boynick P, Hoover LA,. Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection. Laryngoscope 2003; 113: 2086-2090.
32. Suriano M, De Vincentiis M, Colli A, Benfari G, Mascelli A, Gallo A,. Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg 2007; 136: 104-107.
33. Bhattacharyya N, Thornton AF, Joseph MP, Goodman ML, Amrein PC,. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases. Arch Otolaryngol Head Neck Surg 1997; 123: 34-40.
34. Constantinidis J, Steinhart H, Koch M, et al. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000. Otolaryngol Head Neck Surg 2004; 130: 567-574.
35. Beitler JJ, Fass DE, Brenner HA, et al. Esthesioneuroblastoma: is there a role for elective neck treatment? Head Neck 1991; 13: 321-326.
36. Rinaldo A, Ferlito A, Shaha AR, Wei WI, Lund VJ,. Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications. Acta Oto-Laryngol 2002; 122: 215-221.
37. Eich HT, Staar S, Micke O, Eich PD, Stutzer H, Muller R,. Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys 2001; 49: 155-160.
38. Diaz EM Jr, Johnigan RH III, Pero C, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck 2005; 27: 138-149.
39. Levine PA, Gallagher R, Cantrell RW,. Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 1999; 109: 1539-1543.
40. Benfari G, Fusconi M, Ciofalo A, et al. Radiotherapy alone for local tumour control in esthesioneuroblastoma. Acta Otorhinolaryngol Ital 2008; 28: 292-297.
41. Devaiah AK, Andreoli MT,. Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients. Laryngoscope 2009; 119: 1412-1416.
42. Zafereo ME, Fakhri S, Prayson R, et al. Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg 2008; 138: 452-458.
43. Bachar G, Goldstein DP, Shah M, et al. Esthesioneuroblastoma: the Princess Margaret Hospital experience. Head Neck 2008; 30: 1607-1614.
44. Kim HJ, Kim CH, Lee BJ, et al. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma. Auris Nasus Larynx 2007; 34: 493-498.
45. Bragg TMF, Muzaffar K,. Clinicopathological review: esthesioneuroblastoma. Neurosurgery 2009; 64: 764-770.